Bariatric Surgery or Intensive Medical Therapy for Diabetes?

By Charbel C. Khoury, MD
May 11, 2017

Obesity has grown at epidemic rates over the past few decades. According to the most recent data from the Behavioral Risk Factor Surveillance System, adult obesity prevalence now exceeds 35% in four US states, 30% in 25 states and is above 20% in all states.1 Numerous studies have established excess weight as a risk factor for type 2 diabetes, thus adding to the morbidity and mortality of obese patients. While dieting, behavioral approaches, and tight glucose control can limit the long-term complications of diabetes, sustaining adherence is often difficult for most patients. Continue reading “Bariatric Surgery or Intensive Medical Therapy for Diabetes?”

The Link Between Proton Pump Inhibitors and Kidney Disease

By Lea Borgi, MD
April 27, 2017

Proton pump inhibitors (PPI) are among the most prescribed medication in the United States1, with an increasing proportion of US adults reporting using prescription PPI (3.9% in 1999 to 7.8% in 2012) according to the National Health and Nutrition Examination Survey (NHANES).2 However, overall PPI use is most likely underestimated, given their widespread over-the-counter availability. Continue reading “The Link Between Proton Pump Inhibitors and Kidney Disease”